rs121909132

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong

The NM_000085.5(CLCNKB):​c.610G>A​(p.Ala204Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000403 in 1,613,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A204V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000037 ( 0 hom. )

Consequence

CLCNKB
NM_000085.5 missense

Scores

7
10
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 6.30
Variant links:
Genes affected
CLCNKB (HGNC:2027): (chloride voltage-gated channel Kb) The protein encoded by this gene is a member of the family of voltage-gated chloride channels. Chloride channels have several functions, including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport. This gene is expressed predominantly in the kidney and may be important for renal salt reabsorption. Mutations in this gene are associated with autosomal recessive Bartter syndrome type 3 (BS3). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.985
PP5
Variant 1-16048537-G-A is Pathogenic according to our data. Variant chr1-16048537-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 7592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CLCNKBNM_000085.5 linkuse as main transcriptc.610G>A p.Ala204Thr missense_variant 7/20 ENST00000375679.9 NP_000076.2 P51801-1A8K8H0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CLCNKBENST00000375679.9 linkuse as main transcriptc.610G>A p.Ala204Thr missense_variant 7/201 NM_000085.5 ENSP00000364831.5 P51801-1

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152142
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000762
AC:
19
AN:
249318
Hom.:
0
AF XY:
0.0000592
AC XY:
8
AN XY:
135194
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000356
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000370
AC:
54
AN:
1460978
Hom.:
0
Cov.:
64
AF XY:
0.0000303
AC XY:
22
AN XY:
726750
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000515
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000252
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152262
Hom.:
0
Cov.:
32
AF XY:
0.0000806
AC XY:
6
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000523
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000121
ExAC
AF:
0.0000742
AC:
9

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Bartter disease type 3 Pathogenic:3
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 01, 1997- -
Pathogenic, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely pathogenic, criteria provided, single submitterresearchMolecular Biology Laboratory, Fundació PuigvertFeb 01, 2020- -
not provided Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingGreenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic CenterAug 19, 2020- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxOct 08, 2021Reported as a founder mutation in individuals of Spanish ancestry, with variable phenotypic presentation (Garca Castao et al., 2017); Published functional studies suggest a damaging effect due to altered gating properties resulting from decreased sensitivity to extracellular pH and Ca2+ (Bignon et al., 2020); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20931281, 9326936, 31803959, 16391491, 24830959, 28288174, 24058621, 31589614, 33532864, 28381550, 15875219, 31672324) -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 26, 2024This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 204 of the CLCNKB protein (p.Ala204Thr). This variant is present in population databases (rs121909132, gnomAD 0.04%). This missense change has been observed in individual(s) with Bartter syndrome and Gitelman syndrome (PMID: 9326936, 15875219, 24830959). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It is commonly reported in individuals of Spanish ancestry (PMID: 15875219). ClinVar contains an entry for this variant (Variation ID: 7592). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CLCNKB protein function. Experimental studies have shown that this missense change affects CLCNKB function (PMID: 31803959). For these reasons, this variant has been classified as Pathogenic. -
Bartter disease type 3;C4310805:Bartter disease type 4B Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 10, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Uncertain
0.10
D
BayesDel_noAF
Pathogenic
0.23
CADD
Uncertain
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.71
D
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.94
D
M_CAP
Pathogenic
0.51
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Uncertain
2.4
M
PROVEAN
Uncertain
-3.0
D
REVEL
Pathogenic
0.72
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0050
D
Polyphen
0.97
D
Vest4
0.89
MutPred
0.89
Gain of glycosylation at A204 (P = 0.0578);
MVP
0.97
MPC
2.3
ClinPred
0.45
T
GERP RS
4.7
Varity_R
0.46
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121909132; hg19: chr1-16375032; COSMIC: COSV65161552; COSMIC: COSV65161552; API